Research article · 2019
Conference abstractPublished 23 Nov 2012
Pre-analytics- a challenge less heeded
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pre-analytical phase is the most vulnerable part of the total testing process in any clinical trial. The pre-analytical variables include specimen collection, handling, processing, physiological influences and/or interference factors. Pre-analytics is considered to be among the greatest challenges to the laboratory fraternity. However, pre-analytical activities, management of unsuitable specimens and reporting policies are not fully standardized worldwide. There are no internationally accepted guidelines and recommendations as well as related quality measures available for pre-analytical phase. There is large heterogeneity in the criteria for sample rejection, the different strategies by which unacceptable samples are managed, processed and test results reported worldwide. Good practices and compliance with the new strategies for error prevention can lead to a substantial reduction in pre-analytical errors.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 19 Jan 2019
Study on Pre-analytical Errors in a Clinical Biochemistry Laboratory: The Hidden Flaws in Total Testing
Research article · 2016
Identification of the Types and Frequencies of Pre-analytical Errors in the Clinical Biochemistry Laboratory: 1-year Study at Hera’a General Hospital
Conference abstract · 2016
Pre-analytical errors in clinical laboratory: Role of a nurse in reducing the same
Research article · 14 Aug 2014
A STUDY OF PRE-ANALYTICAL ERRORS IN A HOSPITAL BASED CLINICAL BIOCHEMISTRY LABORATORY AND FORMULATION OF MEASURES FOR CORRECTION
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Aparna Jha Ahuja”

